PVLA Butterfly Strategy
PVLA (Palvella Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. Its lead product candidate is QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin) that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania.
PVLA (Palvella Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.43B, a beta of -0.12 versus the broader market, a 52-week range of 20.2-151.18, average daily share volume of 306K, a public-listing history dating back to 2015, approximately 14 full-time employees. These structural characteristics shape how PVLA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.12 indicates PVLA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a butterfly on PVLA?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current PVLA snapshot
As of May 15, 2026, spot at $114.46, ATM IV 66.20%, IV rank 4.41%, expected move 18.98%. The butterfly on PVLA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this butterfly structure on PVLA specifically: PVLA IV at 66.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a PVLA butterfly, with a market-implied 1-standard-deviation move of approximately 18.98% (roughly $21.72 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PVLA expiries trade a higher absolute premium for lower per-day decay. Position sizing on PVLA should anchor to the underlying notional of $114.46 per share and to the trader's directional view on PVLA stock.
PVLA butterfly setup
The PVLA butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PVLA near $114.46, the first option leg uses a $110.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PVLA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PVLA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $110.00 | $11.10 |
| Sell 2 | Call | $115.00 | $8.50 |
| Buy 1 | Call | $120.00 | $6.65 |
PVLA butterfly risk and reward
- Net Premium / Debit
- -$75.00
- Max Profit (per contract)
- $420.98
- Max Loss (per contract)
- -$75.00
- Breakeven(s)
- $110.75, $119.25
- Risk / Reward Ratio
- 5.613
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
PVLA butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on PVLA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$75.00 |
| $25.32 | -77.9% | -$75.00 |
| $50.62 | -55.8% | -$75.00 |
| $75.93 | -33.7% | -$75.00 |
| $101.24 | -11.6% | -$75.00 |
| $126.54 | +10.6% | -$75.00 |
| $151.85 | +32.7% | -$75.00 |
| $177.16 | +54.8% | -$75.00 |
| $202.46 | +76.9% | -$75.00 |
| $227.77 | +99.0% | -$75.00 |
When traders use butterfly on PVLA
Butterflies on PVLA are pinning bets - traders use them when they expect PVLA to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
PVLA thesis for this butterfly
The market-implied 1-standard-deviation range for PVLA extends from approximately $92.74 on the downside to $136.18 on the upside. A PVLA long call butterfly is a pinning play: it pays maximum at the middle strike if PVLA settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current PVLA IV rank near 4.41% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PVLA at 66.20%. As a Healthcare name, PVLA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PVLA-specific events.
PVLA butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PVLA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PVLA alongside the broader basket even when PVLA-specific fundamentals are unchanged. Always rebuild the position from current PVLA chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on PVLA?
- A butterfly on PVLA is the butterfly strategy applied to PVLA (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With PVLA stock trading near $114.46, the strikes shown on this page are snapped to the nearest listed PVLA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PVLA butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the PVLA butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 66.20%), the computed maximum profit is $420.98 per contract and the computed maximum loss is -$75.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PVLA butterfly?
- The breakeven for the PVLA butterfly priced on this page is roughly $110.75 and $119.25 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PVLA market-implied 1-standard-deviation expected move is approximately 18.98%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on PVLA?
- Butterflies on PVLA are pinning bets - traders use them when they expect PVLA to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current PVLA implied volatility affect this butterfly?
- PVLA ATM IV is at 66.20% with IV rank near 4.41%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.